12
Participants
Start Date
October 11, 2018
Primary Completion Date
April 22, 2021
Study Completion Date
April 22, 2021
NPV-EVLP
Lungs deemed marginal based on standard lung donor criteria that meet study eligibility will be physiologically assessed during ex-vivo perfusion. NPV-EVLP of these lungs will be performed with the addition of numerous pre-determined additives. With respect to the decision of lung utilization post-EVLP, eligibility criteria listed in the Post-NPV-EVLP section of the trial will need to be met. Lungs will also be excluded if they are deemed unsuitable based on the clinical judgment of the lung transplant surgeon.
University of Alberta Hospital, Edmonton
University of Alberta
OTHER